Editorspicks
Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials
Numinus will manage two new clinics in Montreal and Vancouver to host trials. VANCOUVER, BC, Nov. 10, 2021 – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a leader in psychedelics-focused mental healthcare, is pleased to ... [Read]
Editorspicks
Numinus to Participate in Microdose Hosted Events: Psychedelic Capital and Wonderland: Miami
VANCOUVER, BC, Oct. 26, 2021 /PRNewswire/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF) (“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in ... [Read]
Editorspicks
Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
Finalized study design and protocol mark major milestone to investigate natural Psilocybin VANCOUVER, BC, Oct. 20, 2021 /CNW/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF) (“Numinus” or the “Company”), a leader in psychedelics-focused mental healthcare, is pleased ... [Read]
Editorspicks
Numinus to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
VANCOUVER, BC, Oct. 6, 2021 /PRNewswire/ — Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the KCSA ... [Read]
Editorspicks
Numinus Completes Acquisition of Neurology Centre of Toronto
Acquisition strengthens clinic portfolio for mental health treatment using psychedelic-assisted therapies VANCOUVER, BC, Sept. 23, 2021 /CNW/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based ... [Read]
Editorspicks
Numinus to Participate in Upcoming Investor Conferences in September 2021
VANCOUVER, BC, Sept. 2, 2021 /CNW/ – Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)(“Numinus” or the “Company”), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in two upcoming ... [Read]